Enlivex Therapeutics Ltd.
ENLV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,205 | -$1,868 | -$3,452 | -$5,176 |
| Dep. & Amort. | $81 | $85 | $90 | $36 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $295 | $293 | $0 |
| Change in WC | -$196 | $172 | -$470 | $664 |
| Other Non-Cash | $25 | $90 | -$1,085 | $392 |
| Operating Cash Flow | -$2,295 | -$1,198 | -$4,624 | -$4,117 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$24 | -$7 | -$32 | -$35 |
| Net Acquisitions | $361 | $0 | $0 | $304 |
| Inv. Purchases | -$7,369 | -$7,337 | -$9,544 | -$1,266 |
| Inv. Sales/Matur. | $11,193 | $8,169 | $12,413 | $4,377 |
| Other Inv. Act. | $0 | $264 | $336 | -$21 |
| Investing Cash Flow | $4,162 | $1,089 | $3,173 | $3,358 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $376 | $1 | $197 | $1,280 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $2 |
| Financing Cash Flow | $376 | $1 | $197 | $1,261 |
| Forex Effect | -$52 | -$25 | $0 | $0 |
| Net Chg. in Cash | $2,191 | -$161 | -$1,254 | $535 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,005 | $2,166 | $3,731 | $3,196 |
| End Cash | $4,196 | $2,005 | $2,477 | $3,731 |
| Free Cash Flow | -$2,319 | -$1,205 | -$4,656 | -$4,153 |